Interleukin 7 receptor alpha (IL7RA) gene that encodes a subunit of IL7 receptor has been reported to be associated with different immunologic disease.
OBJECTIVE:
Multiple Sclerosis (MS) patients have shown an aberrant blood level of soluble form of IL7R protein. The genomic changes in the sequence of this gene have been suggested to be correlated with its altered splicing specially, variants in the exon 6 of the gene have been reported to influence the maintenance or skipping of this exon and control the soluble or insoluble form of the final product. In order to evaluate this changes in the IL7RA gene and to determine a possible correlation between these changes and the MS susceptibility the whole sequence of the exon 6 and 7 and their flanking sequences were analyzed.
METHODS:
In this regard, we investigate the sequence changes of the exon 6 and 7 of the IL7RA gene in 75 relapsing-remitting MS patients and compare the results with 75 healthy control using sequence analyzing.
RESULTS:
The results of the sequence analysis were used in two aspects. The allelic and genotypic estimated frequencies of a reported risk variant rs6897932 in patients and controls in our population confirmed its association with the disease ( 0.009, OR 6.273, for TT genotype). Also, we report a possible hazardous cutoff for changes in a potential exon splicing silencer element (ESS (nt. 20–24)) and its correlation with rs6897932 to confer the risk of developing MS.
CONCLUSION:
In conclusion our results confirm the association between IL7RA exon 6 sequence changes and increased susceptibility for multiple sclerosis.
AkkadD.HoffjanS.Petrasch-ParwezE.BeygoJ.GoldR., and EpplenJ., Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients, Journal of Autoimmunity32 (2009), 110–115.
2.
AxisaP.-P. and HaflerD.A., Multiple sclerosis: genetics, biomarkers, treatments, Current Opinion in Neurology29 (2016), 345–353.
3.
BehbahaniM.H.GalehdariH. and MohagheghM., Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan, Iranian Journal of Neurology13 (2014), 168–171.
4.
Berg-HansenP.MoenS.M.SandvikL.HarboH.F.BakkenI.J.StoltenbergC. and CeliusE.G., Prevalence of multiple sclerosis among immigrants in Norway, Multiple Sclerosis Journal6(21) (2015), 695–702. doi: 1352458514554055.
5.
BielekovaB.MuraroP.A.GolestanehL.PascalJ.McFarlandH.F., and MartinR., Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7, Journal of Neuroimmunology100 (1999), 115–123.
6.
BoothD.ArthurA.TeutschS.ByeC.RubioJ.ArmatiP.PollardJ.HeardR.StewartG. and ConsortiumS.M.G., Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis, Journal of Molecular Medicine83 (2005), 822–830.
7.
ConsortiumI.M.S.G., Risk alleles for multiple sclerosis identified by a genomewide study, N engl J med2007 (2007), 851–862.
8.
EftekharianM.M.NorooziR.SayadA.SarrafzadehS.ToghiM.AzimiT.KomakiA.MazdehM.InokoH. and TaheriM., RAR-related orphan receptor A (RORA): A new susceptibility gene for multiple sclerosis, Journal of the Neurological Sciences369 (2016), 259–262.
9.
EftekharianM.M.SayadA.OmraniM.D.GhannadM.S.NorooziR.MazdehM.MirfakhraieR.MovafaghA.RoshanaeiG. and AzimiT., Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis, Human Antibodies (2016), 1–6.
10.
EtemadifarM.SajjadiS.NasrZ.FiroozeeiT.S.AbtahiS.-H.AkbariM. and Fereidan-EsfahaniM., Epidemiology of multiple sclerosis in Iran: a systematic review, European Neurology70 (2013), 356–363.
11.
EvsyukovaI.BradrickS.S.GregoryS.G. and Garcia-BlancoM.A., Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6, Rna19 (2013), 103–115.
12.
FarazA.YariR.TaheriM.OmraniM.D.SaberiM.MazdehM. and SayadA., The Relation between Age, Gender and Apoptosis Regulator FasL Gene Expression in Multiple Sclerosis Patients, Journal of Biology and Today’s World5 (2016), 50–55.
13.
Garcia-BlancoM.A.BaraniakA.P. and LasdaE.L., Alternative splicing in disease and therapy, Nature Biotechnology22 (2004), 535–546.
14.
GourraudP.A.HarboH.F.HauserS.L. and BaranziniS.E., The genetics of multiple sclerosis: an up-to-date review, Immunological Reviews248 (2012), 87–103.
15.
GregoryS.G.SchmidtS.SethP.OksenbergJ.R.HartJ.ProkopA.CaillierS.J.BanM.GorisA. and BarcellosL.F., Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis, Nature Genetics39 (2007), 1083–1091.
16.
HauserS. and GoodinD., Multiple sclerosis and other demyelinating diseases, Harrisons Principles of Internal Medicine16 (2005), 2461.
17.
HeY.-W. and MalekT.R., Interleukin-7 receptor alpha is essential for the development of gamma delta+ T cells, but not natural killer cells, The Journal of Experimental Medicine184 (1996), 289–293.
18.
LundströmW.HighfillS.WalshS.T.BeqS.MorseE.KockumI.AlfredssonL.OlssonT.HillertJ. and MackallC.L., Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity, Proceedings of the National Academy of Sciences110 (2013), E1761–E1770.
19.
MazdehM.TaheriM.SayadA.BahramS.OmraniM.D.MovafaghA.InokoH.AkbariM.T.NorooziR. and HajilooiM., HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis, Pharmacogenomics17 (2016), 489–498.
20.
McKayF.SwainL.SchibeciS.RubioJ.KilpatrickT.HeardR.StewartG. and BoothD., Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis, Genes and Immunity9 (2008), 1–6.
21.
MillerD.BarkhofF.BerryI.KapposL.ScottiG. and ThompsonA., Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines, Journal of Neurology, Neurosurgery & Psychiatry54 (1991), 683–688.
22.
MueggeK.VilaM. and DurumS., Interleukin-7: a cofactor for V (D) J rearrangement of the T cell receptor beta gene, Science261 (1993), 93–95.
23.
NazdikM.K.TaheriM.OmraniM.D.SajjadiE.Arsang-JangS.KoohparZ.K.InokoH. and SayadA., Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients, Human Antibodies (2016), 1–5.
24.
O’DohertyC.AllozaI.RooneyM. and VandenbroeckK., IL7RA polymorphisms and chronic inflammatory arthropathies, Tissue antigens74 (2009), 429–431.
25.
OlekM.J., Epidemiology, risk factors and clinical features of multiple sclerosis in adults, UpToDateGonzalez-ScaranoF., ed., UpToDate, Waltham, MA, 2010.
26.
PolmanC.H.ReingoldS.C.EdanG.FilippiM.HartungH.P.KapposL.LublinF.D.MetzL.M.McFarlandH.F. and O’ConnorP.W., Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, Annals of Neurology58 (2005), 840–846.
27.
RoifmanC.M.ZhangJ.ChitayatD. and SharfeN., A partial deficiency of interleukin-7Rα is sufficient to abrogate T-cell development and cause severe combined immunodeficiency, Blood96 (2000), 2803–2807.
28.
TaheriM.NematiS.MovafaghA.SaberiM.MirfakhraieR.EftekharianM.M.Arsang-JangS.RezagholizadehA. and SayadA., TRAIL gene expression analysis in multiple sclerosis patients, Human Antibodies24 (2016), 33–38.
29.
TakadaK. and JamesonS.C., Naive T cell homeostasis: from awareness of space to a sense of place, Nature Reviews Immunology9 (2009), 823–832.
30.
Tani-ichiS.ShimbaA.WagatsumaK.MiyachiH.KitanoS.ImaiK.HaraT. and IkutaK., Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations, Proceedings of the National Academy of Sciences110 (2013), 612–617.
31.
ToghiM.TaheriM.Arsang-JangS.OhadiM.MirfakhraieR.MazdehM. and SayadA., SOCS gene family expression profile in the blood of multiple sclerosis patients, Journal of the Neurological Sciences375 (2017), 481–485.
32.
WucherpfennigK.W.NewcombeJ.LiH.KeddyC.CuznerM.L. and HaflerD.A., Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions, Proceedings of the National Academy of Sciences89 (1992), 4588–4592.
33.
XiaZ.WhiteC.C.OwenE.K.KorffA.V.ClarksonS.R.McCabeC.A.CimpeanM.WinnP.A.HoesingA. and SteeleS.U., Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk, Annals of Neurology79 (2016), 178–189.
34.
ZenattiP.P.RibeiroD.LiW.ZuurbierL.SilvaM.C.PaganinM.TritapoeJ.HixonJ.A.SilveiraA.B. and CardosoB.A., Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia, Nature Genetics43(10) (2011), 932–939.
